The Week In Biopharma, May 29 – June 3
Contract Research (CROs)
- Civica signs up Profil to run trials for affordable insulin biosimilars (Germany)
- Coriolis Pharma Invests in New Campus (Germany)
- The Rainwater Charitable Foundation announces partnership with drug discovery teams at the University of Oxford (USA/UK)
- Altos Labs Announces Sponsored Research Agreement with Kyoto University’s CiRA to Foster Cellular Rejuvenation Programming Research (USA/Japan)
- The Lundquist Institute (TLI) Receives Grant from the Johnny Carson Foundation to Support the Training of the Next Generation of COPD Researchers (USA)
Contract Development and Manufacturing (CDMO)
- NanoMosaic Partners with BrickBio to Increase its Neurology Content with Novel Tau (Phospho-Thr217) Antibody (USA)
- BD Unveils World’s First Spectral Cell Sorter with High-Speed Imaging Technology that Sorts Cells Based on Visual Characteristics (USA)
- Abbott plans new wearable sensor for catching diabetic ketoacidosis (USA)
- Stevanato Group Adding Capacity in (Italy)
- mAbxience Continues Manufacturing Capacity Expansion (Spain)
- Vizgen Announces $85.2 Million Series C Financing (USA)
- Watchmaker Genomics Raises $40M Series A Financing to Accelerate Growth and Expand Clinical Sequencing Product Offerings (USA)
- Inception Fertility Launches State-of-the-Art, Long-Term Reproductive Tissue Cryopreservation Storage Solution (USA)
- Gencove and Element Biosciences, Inc. Partner to Offer Low-Pass Whole Genome Sequencing and Analysis with the AVITI™ System (USA)
- RxBIO launches NeoGen Plasma Skin Rejuvenation in the USA – NeoGen Plasma brings a unique solution to treat the whole skin architecture (USA)
- Evonik, U.S. Govt. Invest $220M in Lipid Production Facility for mRNA-based Therapies (Germany)
- Solar Biotech, Inc. Receives Investment from Ingredion Inc. to Accelerate the Development of its Advanced SynBio Bioprocessing Technologies and Proprietary SynBio Products Pipeline (USA)
- Neogen® Launches Prozap® Gamma-Defense Insect Control Solution (USA)
- Silicon Valley-Based Codex Beauty Labs Launches Microbiome-Friendly Bath Salts, A Global First (USA)
- Qosina Introduces 25 New Tube-to-Tube Barb Connectors (USA)
- Croda Forms New Pharma Business (UK)
- RCPE and InSilicoTrials Expand Mfg. Processes Pact (UK/Italy)
- Jubilant HollisterStier LLC enters into cooperative agreement of $149.6 Mn with US Government to expand critical vaccine manufacturing capacity (USA)
Biopharma
- Bristol Myers strikes up Roche rivalry with $4.1B Turning Point buy (USA)
- Prettying itself up for partners, Athersys lays off 70% of staff and most of C-suite (USA)
- Lilly to Invest $2.1B in Indiana Manufacturing Sites (USA)
- Zylö Therapeutics Closes $5.225 Million Series B Financing (USA)
- ProfoundBio Announces Completion of $70 Million Series A+ Financing to Advance Antibody-Drug Conjugate (ADC) Programs into the Clinic (China)
- Boehringer Ingelheim enters global licensing agreement to develop and commercialize innovative antibodies from A*STAR for targeted cancer therapies (Germany/Singapore)
- Proxygen Announces Strategic Collaboration with Merck to Develop Molecular Glue Degraders (Austria/USA)
- Oncology biotech Atreca pulled into industry’s layoff whirlpool, cuts 25% of staff (USA)
- EtiraRx’s Licensed ERX-41 Identified as a Potential New Oral Therapy for Multiple Cancers, Company Prepares for Clinical Trials (USA)
- Invenshure Launches MEKanistic Therapeutics™ (USA)
- ProfoundBio Announces Completion of $70 Million Series A+ Financing to Advance Antibody-Drug Conjugate (ADC) Programs into the Clinic (China)
- Vernal Biosciences Raises $21 Million to Accelerate mRNA Manufacturing Growth (USA)
- Caris Life Sciences, Prostate Cancer Clinical Trial Consortium and Sorrento Therapeutics Announce Collaboration to Advance Precision Medicine Development Using Comprehensive Genomic Profiling (USA)
- Biogen, Samsung Bioepis launch first US biosimilar, a copycat of Roche’s Lucentis, at 40% discount (USA)
- Regeneron purchases Sanofi’s stake in Libtayo collaboration (USA/France)
- Asher Bio Announces Clinical Trial Collaboration with Merck to Evaluate AB248 in Combination with KEYTRUDA® (pembrolizumab) in Patients with Locally Advanced or Metastatic Solid Tumors (USA)
- Immatics and Bristol Myers Squibb Expand Strategic Alliance to Develop Gamma Delta Allogeneic Cell Therapy Programs (Germany/USA)
- CMP Pharma, Inc Announces that Norliqva®, the First and Only FDA-approved Liquid Solution of Amlodipine, is Now Available (USA)
- Codagenix Receives FDA Clearance of Investigational New Drug Application for Live-Attenuated, Intranasal RSV Vaccine Candidate CodaVax™-RSV (USA)
- SciNeuro Pharmaceuticals Announces a License and Option Agreement with GSK to Progress Development of Novel Therapies for CNS Diseases (China/USA)
- Theolytics starts a £1M project in collaboration with the University of Sheffield, supported by Innovate UK to develop a novel therapy for multiple myeloma patients (UK)
- Astellas and GO Therapeutics Enter into Strategic Research and License Agreement to Develop Novel Antibodies for Immuno-Oncology (Japan/USA)
- Transine Therapeutics Announces Final Closing of its Seed Round at £13.7m to Accelerate its Platform and Portfolio Development (UK)
- Willow Biosciences Expands Its Portfolio with A New Partnered Pharmaceutical Project (Canada)
- FDA Approves Label Extension for Evrysdi® for Infants with Spinal Muscular Atrophy Under 2 Months Old (USA)
- Aruna Bio Advances Therapeutic Development for Traumatic Brain Injury (USA)
- SciSparcv unlocks nasal cannabinoid delivery via Polyrizon pact (Israel)
- Bouncing back from late-phase fail, Minoryx pockets €51M to guide rare disease drug to market (Spain)
- GSK to Acquire Affinivax in Deal Valued at $3.3B (UK)
- Agenus Enters 3 New Clinical Collaborations (USA)
- Evotec Adds Cell Therapy Mfg. Facility with Rigenerand Acquisition (Germany)
- NRG Therapeutics Announces £2.68M Innovate UK Award to Develop New Medicines to Treat Parkinson’s and Motor Neuron Disease (UK)
Artificial Intelligence
- Diabeloop rounds up €70M to take AI-powered insulin delivery tech global (France)
- Accuray and Limbus AI Inc. Partner to Leverage Limbus’ Innovative AI-driven Technology to Enhance Accuray Adaptive Radiotherapy Solutions (USA/Canada)
- L7 Informatics and Triumvira Immunologics Announce Agreement to Digitalize Manufacturing of Next-Generation Cell Therapies (USA)
